Elevated levels of plasma PAI-1 are associated with an increased risk of cardiovascular events and are observed in subjects with type 2 diabetes (T2D) and obesity. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.